Your session is about to expire
← Back to Search
Clinical Documentation Physician Compensation Incentives
N/A
Waitlist Available
Led By David S Burstein, MD MS
Research Sponsored by Rush University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline documentation over 6 a week period to incentivized documentation over a 12 week period.
Awards & highlights
No Placebo-Only Group
Summary
This trial will use physician compensation incentives to improve documentation of clinically significant details for six common diagnoses in outpatient general internal medicine. The goal is to improve communication of clinically significant diagnostic information among physicians, reducing suboptimal treatment plans, overuse, medical error, and cognitive burden.
Eligible Conditions
- Compensation Incentives
- Clinical Documentation
- Diagnostic Errors
- Physician Work Environment
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline documentation over 6 a week period to incentivized documentation over a 12 week period.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline documentation over 6 a week period to incentivized documentation over a 12 week period.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Clinical Documentation
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Incentivized PeriodExperimental Treatment1 Intervention
3 month period during which time clinicians will receive compensation incentives for their performance in the program to improve clinical documentation.
Group II: Baseline PeriodActive Control1 Intervention
Run-in non-incentivized period for all participants.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Compensation Incentives to improve Clinical Documentation
2022
N/A
~40
Find a Location
Who is running the clinical trial?
Rush University Medical CenterLead Sponsor
439 Previous Clinical Trials
250,214 Total Patients Enrolled
David S Burstein, MD MSPrincipal InvestigatorAssistant Professor
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Baseline Period
- Group 2: Incentivized Period
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.